Natural history of noninfectious, ibrutinib-attributable adverse events in patients with chronic lymphocytic leukemia

被引：1
|
作者：
Khountham, Soun [1 ]
Shindiapina, Polina [1 ]
Mo, Xiaokui [2 ]
Lachowiez, Curtis [3 ]
Wiczer, Tracy [4 ]
Mousa, Luay [1 ]
Rogers, Kerry A. [1 ]
Andritsos, Leslie A. [1 ]
Woyach, Jennifer A. [1 ]
Byrd, John C. [1 ]
Spurgeon, Stephen E. [3 ]
Awan, Farrukh T. [5 ]
机构：
[1] Ohio State Univ, Ctr Comprehens Canc, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA
[3] Oregon Hlth & Sci Univ, Div Hematol & Med Oncol, Portland, OR 97201 USA
[4] Ohio State Univ, Ctr Comprehens Canc, Dept Pharm, Columbus, OH 43210 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Div Hematol & Med Oncol, Dallas, TX 75390 USA
来源：
LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 03期
关键词：
ATRIAL-FIBRILLATION; OUTCOMES; THERAPY;
D O I：
10.1080/10428194.2020.1838508
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：716 / 721
页数：6
相关论文
共 50 条
  • [41] Response to Comment on: "Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients"
    Brown, Jennifer R.
    HAEMATOLOGICA, 2022, 107 (06) : 1491 - 1492
  • [42] Depth of response and progression-free survival in chronic lymphocytic leukemia patients treated with ibrutinib
    Sigmund, Audrey M.
    Huang, Ying
    Ruppert, Amy S.
    Maddocks, Kami
    Rogers, Kerry A.
    Jaglowski, Samantha
    Bhat, Seema A.
    Kittai, Adam S.
    Grever, Michael R.
    Byrd, John C.
    Woyach, Jennifer A.
    LEUKEMIA, 2022, 36 (08) : 2129 - 2131
  • [43] Molecular Composition and Kinetics of B Cells During Ibrutinib Treatment in Patients with Chronic Lymphocytic Leukemia
    Veyhe, Solja Remisdottir
    Cedile, Oriane
    Dahlmann, Sara Kamuk
    Krejcik, Jakub
    Abildgaard, Niels
    Hoyer, Thor
    Moller, Michael Boe
    Thomassen, Mads
    Juul-Jensen, Karen
    Frederiksen, Henrik
    Dybkaer, Karen
    Hansen, Marcus Hoy
    Nyvold, Charlotte Guldborg
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [44] BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia
    Falchi, Lorenzo
    Baron, Jessica M.
    Orlikowski, Carrie Anne
    Ferrajoli, Alessandra
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2016, 8
  • [45] Impact of adherence to ibrutinib on clinical outcomes in real-world patients with chronic lymphocytic leukemia
    Collins, James
    Stump, Sarah E.
    Heiling, Hillary
    Muir, Michele
    Deal, Allison
    Proco, Darrian
    Nguyen, Catharine
    Cozad, Monica
    Mato, Anthony
    Coombs, Catherine C.
    Muluneh, Benyam
    LEUKEMIA & LYMPHOMA, 2022, 63 (08) : 1823 - 1830
  • [46] Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia
    Hamadeh, Issam S.
    Patel, Jai N.
    Jacobs, Ryan
    Zeng, Hang
    He, Jiaxian
    Hu, Bei
    Moyo, Tamara Kay
    Soni, Amy
    Park, Steven
    Copelan, Ed
    Avalos, Belinda
    Hamilton, Alicia
    Steuerwald, Nury
    Ghosh, Nilanjan
    CLINICAL CANCER RESEARCH, 2023, 29 (23) : 4941 - 4948
  • [47] Efficacy and Safety of Bendamustine and Ibrutinib in Previously Untreated Patients With Chronic Lymphocytic Leukemia: Indirect Comparison
    Andrasiak, Iga
    Rybka, Justyna
    Knopinska-Posluszny, Wanda
    Wrobel, Tomasz
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (05): : 268 - 273
  • [48] Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma
    Shadman, Mazyar
    Salkar, Monika
    Srivastava, Bhavini
    Karve, Sudeep
    Emond, Bruno
    Gogna, Priyanka
    Manceur, Ameur M.
    Lafeuille, Marie-Helene
    Rava, Andrew
    Sun, Haiyan
    Howarth, Amanda
    Tomicki, Samantha
    Agatep, Barnabie
    Jones, Barton
    Franceschini, Erin
    Saifan, Chadi
    Bacchus, Shaffee
    Roeker, Lindsey
    Stephens, Deborah M.
    LEUKEMIA & LYMPHOMA, 2024,
  • [49] Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinib
    Barrientos, Jacqueline C.
    Burger, Jan A.
    Byrd, John C.
    Hillmen, Peter
    Zhou, Cathy
    Ninomoto, Joi
    James, Danelle F.
    Kipps, Thomas J.
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1000 - 1005
  • [50] Cutaneous adverse-events in patients treated with Ibrutinib
    Pileri, Alessandro
    Guglielmo, Alba
    Agostinelli, Claudio
    Evangelista, Valeria
    Bertuzzi, Clara
    Alessandrini, Aurora
    Bruni, Francesca
    Starace, Michela
    Massi, Alice
    Broccoli, Alessandro
    Patrizi, Annalisa
    Zinzani, Pier Luigi
    Piraccini, Bianca Maria
    DERMATOLOGIC THERAPY, 2020, 33 (06)
12345